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Abstract  
This study investigates the effect of dietary supplementation with Coriandrum sativum L. seed aqueous extract (CS) to a high fat diet (HFD), for induced 
insulin resistance (IR) C57BL/6J mice. Changes in body weight, food intake, feed efficiency ratio, fasting blood glucose (FBG), plasma insulin, fasting 
insulin resistance index (FIRI), plasma and hepatic triglyceride (TG), total cholesterol (TC) and, plasma free fatty acid (FFA) levels were evaluated in control 
and treated groups. Also, the diameter, surface area and number of adipocytes and, intraperitoneal glucose tolerance test (IPGTT) and intraperitoneal insulin 
response test (IPRTT) were performed. CS supplementation (1% and 3% w/w) to HFD fed mice (for 12 weeks) significantly prevented HFD induced 
increment in body weight gain, food intake, feed efficiency, FBG, plasma insulin, FIRI, plasma and hepatic TG and TC and, plasma FFA, adipocyte diameter 
and surface area along with decrement in adipocyte number. Also, improved responses were recorded in the IPGTT and IPRTT in CS supplemented HFD fed 
mice. These set of changes were comparable to the rosiglitazone (0.05%) supplemented HFD fed mice. Our findings suggest that CS improves insulin 
sensitivity primarily by mitigating plasma and tissue lipids and, adipocyte hypertrophy. 
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Resumen 
En este estudio se investigó el efecto de un extracto acuoso de semillas de Coriandrum sativum L. (CS), adicionado a una dieta con alto contenido graso en 
ratones C57BL/6J, con resistencia a la insulina inducida. Los cambios en el aumento de peso corporal, consumo de alimento, eficiencia alimenticia, glicemia, 
insulina plasmática, índice de resistencia a la insulina, triglicéridos hepáticos y plasmáticos,  colesterol total y concentración plasmática de ácidos grasos 
libres, fueron evaluados en grupos control y tratados. Adicionalmente se controló, el diámetro, superficie y número de adipocitos, prueba de tolerancia a la 
glucosa intraperitoneal y la prueba de respuesta de la insulina por vía intraperitoneal.  La adición de  CS (1% y 3% w / w) a la dieta con alto contenido graso  
a ratones (12 semanas) previno de manera significativa el incremento de peso, la ingesta de alimentos, la eficiencia alimenticia, FBG, la insulina plasmática, 
FIRI, los triglicéridos hepáticos y plasmáticos, el colesterol total, ácidos grasos libres plasmáticos, el diámetro de los adipocitos y la superficie junto con el 
decremento en el número de los adipocitos. Además, mejoras de la respuesta se registraron en el IPGTT y IPRTT. Este conjunto de cambios fue comparable 
al obtenido con rosiglitazona (0,05%), adicionada a la dieta con alto contenido graso. Estos hallazgos sugieren que el CS mejora la sensibilidad a la insulina 
principalmente por la mitigación  de  los lípidos del plasma, del tejido y la hipertrofia del adipocito. 
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INTRODUCTION 
Changes in lifestyle and intake of caloric rich diets 
have predisposed the populace to obesity. Type 2 
diabetes (T2D) is also closely associated with obesity 
and is characterized by an insulin resistance (IR) 
severely affecting glucose disposal (Frőde and 
Medeiros, 2008). Treatment of IR involves popular 
lipid lowering and insulin sensitizing drugs that have 
been associated with many side effects. Multiple drug 
usage is the necessary option for maintaining 
glycaemic levels and other associated manifestation in 
T2D patients (Gerich, 2001). These compelling 
reasons provide impetus for investigating the 
medicinal properties of herbs for use as alternatives in 
the treatment of T2D on a global scale. In this context, 
World Health Organization (WHO) has estimated that, 
about 25% of modern medicines are derived from 
plants and that, the global market for herbal medicine 
currently stands at over 60 million US$ annually 
(WHO, 2009). 
Coriandrum sativum L. (Apiaceae) (CS) is an 
annual herb, the fresh leaves and dried seeds of which 
form part of Middle Eastern, Mediterranean, Indian, 
Latin American, African and Southeast Asian cuisines. 
Decoction and tincture of powdered seeds of CS alone 
or in combination with other herbal agents are 
recommended for dyspeptic complaints, loss of 
appetite, convulsion, insomnia and anxiety (Grieve, 
1971). It is also used as medication against diabetes, 
indigestion, flatulence, renal disorders and as a 
diuretic agent in India and Morocco (Grieve, 1971; 
Emamghoreishi et al., 2005). It is also used in 
urethritis, cystitis, urinary tract infection, urticaria, 
rashes, burns, sore throat, vomiting, indigestion, 
nosebleed, cough, allergies, hay fever, dizziness and 
amoebic dysentery (Grieve, 1971; PDR-HM, 2004).  
Phytochemical constituents of CS seeds have 
been studied extensively and its analysis has revealed 
the presence of polyphenols (rutin, caffeic acid 
derivatives, ferulic acid, galic acid, and chlorogenic 
acid), flavonoids (quercetin and isoquercetin) and β-
carotenoids (Melo et al., 2003). The essential oil 
obtained from CS seeds contains α and β- pinene, 
camphor, citronellol, coriandrol, p-cymene, geraniol, 
geranyl acetate, limonene, linalool, myrcene, α and β 
phellandrene and α and β-terpinene. Also   many fatty 
acids have been identified in the seeds oil. A large 
number of water soluble compounds have been 
identified including monoterpenoid glycosides, 
monoterpenoid glucose sulfate and other glycosides 
(Sergeeva, 1975; Ishikawa et al., 2003). The 
pharmacological activities of various extracts and of 
the essential oil of CS seeds have been also studied. 
The essential oil has been found to possess 
antimicrobial (Baratta et al., 1998) and antifungal 
properties (Garg and Siddiqui, 1992). Its efficacy as a 
hypoglycemic (Gray and Flatt, 1999), hypolipidemic 
(Chithra and Leelamma, 1997; Chithra and Leelamma, 
1999; Lal et al., 2004), hypocholesterolemic 
(Dhanapakiam et al., 2008), antihypertensive (Medhin 
et al., 1986), antioxidant (Melo et al., 2003; Ramadan 
et al., 2003; Bajpai et al., 2005), antimutagenic 
(Cortes-Eslava et al., 2004), anxiolytic 
(Emamghoreishi et al., 2005), antimicrobial (Kubo et 
al., 2004; Cantore et al., 2004), larvicidal (Consoli et 
al., 1988) and post-coital antifertility (Al-Said et al., 
1987) agent have also been reported.  
As CS has been used as traditional anti-
diabetic herbal agent and it’s hypoglycemic and 
insulin secretor effects have been evaluated in 
streptozotocin induced diabetic rats (Eidi et al., 2009; 
Swanston-Flatt et al., 1990), the present study was 
designed to assess the efficacy of aqueous extract of 
CS in alleviating IR in high fat diet fed model of T2D. 
 
MATERIALS AND METHODS 
Plant Extract 
CS seeds were procured from local ayurvadic 
medicinal shop of Vadodara, India. Hundred grams of 
powdered seeds were boiled at 100°C for 3 hrs in 
distilled water. Resulting filtrate was concentrated in a 
hot air oven until it formed a semisolid paste, which 
was then freeze dried. The yield was 12% w/w. Two 
doses (1% and 3%) of aqueous extract of CS were 
mixed with high fat diet. 
 
Experimental Animals 
Male C57BL/6J mice (6-8 weeks of age) were 
purchased from the National Centre for Laboratory 
Animal Sciences (NCLAS), National Institute of 
Nutrition (NIN), Hyderabad, INDIA. They were 
housed and maintained in clean polypropylene cages 
and fed with standard laboratory diet (SLD) and water 
ad libitum. The experiments were carried out 
according to the guidelines of the Committee for the 
Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA), India and approved by the animal 
ethical committee of the Department of Zoology, The 
Maharaja Sayajirao University of Baroda, Vadodara 
(Approval No.827/ac/04/CPCSEA) . 
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Experimental Design 
30 animals were randomly allocated into 5 groups of 6 
animals each. Mice were fed with standard laboratory 
diet (SLD) or high fat diet (HFD) for 12 weeks (Jadeja 
et al., 2010; Thounaojam et al., 2010). CS or 
Rosiglitazone (ROS) were given to the experimental 
animals by mixing with HFD. 
 
Group I (SLD): Mice were fed with SLD 
Group II (HFD): Mice were fed with HFD 
Group III (HFD+CS1%): Mice fed with HFD 
containing CS extract (1% w/w) 
Group IV (HFD+CS3%): Mice fed with HFD 
containing CS extract (3% w/w) 
Group V (HFD+ROS): Mice fed with high fat diet 
containing Rosiglitazone (0.05% w/w).  
 
At the end of the experimental period, blood 
was collected from retro orbital sinus in EDTA coated 
vial under mild ether anesthesia. Plasma was obtained 
by cold centrifugation (4°C) of the vials for 10 min at 
3000 rpm. Later, animals were sacrificed by cervical 
dislocation and epididymal fat pad were excised, 
weighted and fixed in 4% buffered paraformaldehyde. 
 
Body weight, food intake and feed efficiency 
Known quantity of food (SLD or HFD) was given to 
the respective experimental groups and food intake 
was measured daily. Feed efficiency ratio (FER) was 
expressed as the total weight gain of an experimental 
animal during 12 weeks ÷ the total food intake. 
 
Plasma and hepatic lipids 
Plasma free fatty acid (FFA) content was estimated by 
the method of Itaya and Ui, (1965) while, triglyceride 
(TG) and total cholesterol (TC) contents were 
estimated by using enzymatic kits (Reckon 
Diagnostics. Ltd, Vadodara, India) in a semi 
autoanalyser (Micro lab 300 L, Merck). Total lipids 
were extracted from liver of control and experimental 
animals with chloroform: methanol (2:1) (Folch et al., 
1957) and hepatic Free fatty acids were assayed in the 
same (Itaya and Ui, 1965). Known quantity of lipid 
extract was than dissolved in 1% Triton X-100 
(Thounaojam et al., 2010) and TC and TG were 
assayed using above kits. 
 
Blood glucose, plasma insulin and fasting insulin 
resistance index (FIRI) 
Animals were fasted overnight (for 12 hrs) and later 
blood glucose was measured in whole blood sample 
obtained from tail vein (by one touch glucometer, 
Sugar Scan, HMD BIOMEDICAL INC., India). 
Plasma insulin was assayed using Mouse ELISA kit 
(Mercodia Developing Diagnostics Ltd, Sweden). 
Fasting insulin resistance index (FIRI) was expressed 
as: - Fasting insulin (pmol/l) x Fasting blood glucose 
(mg/dl) ÷ 25. 
 
Intraperitoneal glucose tolerance test (IPGTT) 
Fasting (12 hrs) blood glucose was measured in whole 
blood (by one touch glucometer, Sugar Scan, HMD 
BIOMEDICAL INC., India) obtained from tail vein (0 
min). Later, glucose solution was injected 
intraperitoneally (2 g/kg) and blood glucose was 
assayed at 30, 60, 90 and 120 min and the tolerance 
curves plotted. Area under the curve (AUCglucose) was 
calculated based on the trapezoid rule (Graph Pad 
Prism version 3.0). 
 
Intraperitoneal insulin response test (IPIRT) 
Overnight fasted mice received insulin (Aventis 
Pharma Deutschland GmbH, Mumbai, India) 0.2 U/kg 
body weight by intraperitoneally. Blood samples were 
collected from tail vein at 0 min (before 
administration) and subsequently at 10, 20, 30 and 60 
min after administration of insulin. Blood glucose was 
measured in whole blood (by one touch glucometer, 
Sugar Scan, HMD BIOMEDICAL INC., India). KITT 
was determined with the formula: KITT= 0.693×100 ÷ 
T½. Where T½ is half-life of plasma glucose decay was 
obtained with the formula: T½= ln2 ÷ ω. Where, ω 
constant of plasma glucose disintegration was obtained 
with the formula: ω = lnC1 - lnC2 ÷ T2 - T1 with 
glucose concentration C1 at time T1 (10 min) and C2 
at T2 (60 min) (Thounaojam et al., 2010). 
 
Histology of epididymal fat pad 
Epididymal fat pad was fixed in 4% buffered 
paraformaldehyde, dehydrated in graded alcohol series 
and embedded in paraffin wax. Five μm sections were 
cut (by Leica RM 2115 Microtome) and stained with 
hematoxyline and eosin (H&E) and examined under 
Leica microscope. Photographs of adipocytes were 
taken with Canon power shot S7 digital Camera (400 
X). To quantify adipocyte number and diameter, the 
H&E stained sections were analyzed using an image 
analysis system (Image Pro-Plus, Silver Spring, MD). 
 
Statistical analysis 
Statistical analysis of the data was done by one way 
ANOVA followed by Bonferroni’s multiple 
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comparison test and results were expressed as mean ± 
S.E.M (Using Graph Pad Prism version 3.0 for 
Windows, Graph Pad Software, San Diego California 
USA). 
 
RESULTS 
Body weight gain and feed efficiency ratio 
HFD group recorded significant increase in body 
weight gain but not in food intake and feed efficiency 
ratio as compared to SLD (p<0.01). HFD+CS (CS 1% 
& CS 3%) recorded significantly dose dependent 
decrement in body weight gain, food intake and feed 
efficiency ratio as compared to HFD fed mice (Table 
1). HFD+ROS group also showed decrement of the 
said parameters which were comparable to 
HFD+CS1% but, HFD+CS3% was the most efficient 
in inducing.  
 
Table 1. Effect of CS extract and Rosiglitazone on Body weight, Food intake and Feed efficiency ratio 
 
 SLD HFD HFD+CS1% HFD+CS3% HFD+ROS 
Initial body 
weight(g) 
24.40±0.86 22.53±0.79 23.32±0.24 22.22±1.34 24.00±0.64 
Final body 
weight(g) 
29.00±0.70 32.42±0.28 30.32±0.30 25.50±1.12 31.16±0.59 
Weight gain 
(g) 
4.32±0.69 9.86±0.59c 7.03±0.16B 3.28±0.36C 7.16±0.074B 
Food intake 
(g/day) 
2.26±0.1979 3.72±0.4195a 2.39±0.1234A 1.88±0.1137B 3.02±0.089NS 
Feed 
efficiency 
ratio 
0.02±0.002 0.03±0.001b 0.03±0.002NS 0.02±0.002A 0.02±0.002A 
Data are expressed as the mean ± S.E.M. Where, a) p<0.05, b) p<0.01, c) p<0.001 and ns: non significance when, SLD vs 
HFD. A) p<0.05, B) p<0.01, C) p<0.001 and NS: non significance when, HFD vs HFD+CS1%,  HFD+CS3% and HFD+ROS 
 
Plasma and hepatic lipid profile 
Plasma and hepatic TC and TG levels and plasma FFA 
level were significantly elevated in HFD group as 
compared to SLD group (p<0.01). CS supplemented 
HFD fed groups (CS 1% & CS 3%) and HFD+ROS 
were significantly (p<0.01) able to attenuate the effect 
of HFD as was evident in form of decrement in levels 
of hepatic and plasma TC and TG and plasma FFA 
(Table 2). 
 
Fasting blood glucose (FBG) and serum Insulin 
levels 
FBG, plasma insulin level and FIRI were significantly 
higher in HFD group (p<0.01) as compared to SLD 
group. However, CS supplementation of HFD mice 
groups recorded significantly lowered levels of these 
parameters in dose dependent manner as compared to 
HFD group (p<0.01; Table 2). 
 
Intraperitoneal glucose tolerance test and 
Intraperitoneal insulin response test 
IPGTT of HFD fed mice recorded significant elevation 
in glucose level at 30 min that failed to return to its 
normal level at 120 min. AUCglucose of HFD fed mice 
was significantly higher compared to SLD mice 
(p<0.01). However, IPGTT of CS supplemented HFD 
mice showed dose dependent decrement in AUCglucose 
compared to that of HFD fed mice (p<0.01). 
HFD+ROS group also recorded a decrement in 
AUCglucose values compared to HFD group (Fig. 1).  
IPIRT plots of glucose levels of HFD and 
SLD fed mice were comparable, however, CS 
supplemented HFD fed mice showed significant 
improvement in the IPIRT curves. The same was 
evident in the form of higher KITT values in these 
groups compared to the HFD group (p<0.01). 
HFD+ROS group also recorded higher KITT values of 
IPIRT as compared to HFD group (Fig. 2).  
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Table 2. Effect of CS extract and Rosiglitazone on plasma Glucose and serum Insulin 
 
 SLD HFD HFD+CS1% HFD+CS3% HFD+ROS 
Plasma 
TC(mg/dl) 68.50±10.56 142.70±7.63c 103.00±7.0B 74.80±8.23C 81.25±11.09C 
TG(mg/dl) 50.00±5.22 152.30±20.67c 102.30±9.24C 76.50±4.85C 70.25±11.69C 
FFA(mg/dl) 35.32±2.32 101.00±10.15c 79.23±3.84NS 37.97±2.08C 50.28±3.70B 
Glucose(mg/dl) 110.00±5.21 162.80±3.47c 131.30±10.71A 117.00±8.31C 128.00±4.35C 
Insulin(pmol/L) 38.89±3.81 79.00±4.34c 56.43±2.96B 44.97±4.44C 46.70±3.41C 
FIRI 168.70±8.42 513.70±26.10c 309.20±21.93C 201.10±25.35C 243.70±21.48C 
Liver 
TC(mg/dl) 17.23±2.34 50.75±7.33b 34.75±5.07NS 23.50±2.90B 24.44±2.66B 
TG(mg/dl) 27.00±3.06 80.25±7.46c 67.50±6.41NS 33.65±5.49B 44.25±4.34B 
Adipocyte 
Diameter(µm) 30.00±1.57 78.70±3.71c 61.20±3.13B 33.20±2.26C 44.10±3.05C 
Surface area(µm2) 706.00±86 4862.00±125c 2940.10±108B 860.00±93C 1520.60±122C 
Number(cells/1x106 
µm2) 
941±81 
 
177±76c 
 
580±66B 
 
864±62C 
 
748±75C 
 
Data are expressed as the mean ± S.E.M Where, p<0.05, b) p<0.01, c) p<0.001 and ns: non significance when, SLD vs HFD. 
A) p<0.05, B) p<0.01, C) p<0.001 and NS: non significance when, HFD vs HFD+CS1%,  HFD+CS3%  and HFD+ROS 
 
 
 
Adipocyte diameter, number and surface area 
Microscopic examination of epididymal fat pad of 
HFD group recorded a significant increase in diameter 
and surface area of adipocytes compared to the 
adipocytes of SLD group (p<0.01). CS supplemented 
HFD groups showed adipocytes with mixed 
dimensions. However, the overall score of 
measurements of diameter and surface area of 
adipocytes recorded in HFD+CS (1% & 3%) were 
significantly lower than that of HFD group. The total 
number of adipocytes counted in a unit area in 
HFD+CS (1% & 3%) groups were significantly higher 
(p<0.01) than in the HFD group. These numbers were 
comparable to SLD or HFD+ROS groups (Table 2). 
HFD+ROS group also showed moderate decrement in 
diameter of adipocyte compared to HFD group. 
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Fig.1. Effect of CS extract and Rosiglitazone on IPGTT and AUC 
0 30 60 90 120
0
25
50
75
100
125
150
175
200
225
250
275
300
325
350
SLD
HFD
HFD+CS1%
HFD+CS3%
HFD+ROS
min
Pl
as
m
a 
gl
uc
os
e 
le
ve
l (
m
g/
dl
) Area Under Curve (AUC)
SL
D
HF
D
HF
D+
CS
1%
HF
D+
CS
3%
HF
D+
RO
S
0
10000
20000
30000
40000
c
C
C
B
Experimental groups
m
g/
dl
.m
in
 
Data are expressed as the mean ± S.E.M  a) p<0.05, b) p<0.01, c) p<0.001 and ns: non significance when, SLD vs HFD. A) 
p<0.05, B) p<0.01, C) p<0.001 and NS: non significance when, HFD vs HFD+CS1%, HFD+CS3% and HFD+ROS 
 
 
Fig.2. Effect of CS extract and Rosiglitazone on IPIRT and KITT 
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Data are expressed as the mean ± S.E.M a) p<0.05, b) p<0.01, c) p<0.001 and ns: non significance when, SLD vs HFD. A) 
p<0.05, B) p<0.01, C) p<0.001 and NS: non significance when, HFD vs HFD+CS1%, HFD+CS3% and HFD+ROS 
 
 
DISCUSSION 
C57BL/6J mouse is a popular experimental model 
used in pre-clinical investigations of herbal and 
synthetic therapeutic agents against diabetes and 
obesity as there mice undergo a series of physiological 
changes when fed with high fat diet for 12-15 weeks. 
These changes are similar to the onset and progression 
of T2D and IR (Ahrén et al., 1997). In these mice, 
HFD induced IR is preceded by hyperlipidemia and 
visceral adiposity. 
Our study has shown significant increment in 
body weight gain, food intake and feed efficiency ratio 
in HFD mice, well reflected in the form of significant 
increment in the weight of epididymal fat pad 
(personal communication). However, CS (1% & 3%) 
supplementation of HFD mice significantly prevented 
the characteristic body weight gain and increase in 
epididymal fat pad mass possibly due to decreased 
food intake. Previous studies have reported that insulin 
sensitivity in T2D patients improved with weight loss 
(DeFronzo and Ferrannini, 1991). CS supplemented 
HFD fed mice minimized the increase in hepatic and 
plasma TC and TG levels characteristic of HFD. These 
observations are in accordance with a previous report 
of Chithra and Leelamma (1997) on CS induced 
decrement in lipid profile of Sprauge dawly rats 
maintained on a hyperlipidemic diet. It has been 
reported that, increase in circulating level of plasma 
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FFA contributes to an increase in IR and inhibition of 
glucose uptake by skeletal muscles and other 
peripheral tissues (Boden et al., 1997). Also, in ob/ob 
mice, hyperinsulinemia develops due to decreased 
sensitivity towards insulin in liver, muscle and adipose 
tissues (Genuth et al., 1971). CS supplemented HFD 
mice (1% & 3%) were able to improve IR by 
decreasing levels of plasma FFA and insulin titer.  
Also, an improvement in fasting plasma glucose levels 
and FIRI values provide ample testimony to CS 
induced improvement of IR in HFD fed mice. IPGTT 
and IPIRT tests were carried out in control and 
experimental mice to assess CS induced possible 
improvement in insulin sensitivity and the results 
obtained were compared with HFD group. Lower 
AUCglucose values and higher KITT indices recorded in 
HFD+CS (1% & 3%) groups are attributable to 
improved insulin sensitivity in CS supplemented HFD 
fed mice. These mitigating changes are comparable to 
ROS induced changes in visceral adiposity and IR. 
 
Figure 3. Photomicrograph of Epididymal fat pad showing the effect of CS extract and Rosiglitazone on adipocyte 
morphology 
 
 
The histological manifested changes in 
adipocyte mass and size of HFD are attributable to diet 
induced lipogenesis. Co-presence of CS in HFD is 
able to resist the adiposity changes caused due to fat 
rich diet. Adipocyte hypertrophy is a strong evidence 
of visceral obesity and IR (Flier, 2004; Wellen and 
Hotamisligil, 2005) and in fact, the larger adipocytes 
are associated with IR and smaller ones with better 
insulin sensitivity (Okuno et al., 1998; Kubota et al., 
1999; Kodowaki, 2000). The sizes of adipocytes in 
HFD and HFD+CS groups of mice in this context 
could easily reflect the higher IR in the former and 
greater insulin sensitivity in the later. The observations 
on adipocyte number and size in HFD+CS (1%) and 
HFD+CS (3%) also tend to suggest the dose 
dependent favorable influence of the extract in 
preventing diet induced visceral adiposity and IR. 
The observed significant anti-hyperglycemic 
effect of CS extracts might also suggest increased 
peripheral glucose uptake as well as decreased 
transport of glucose across the intestinal epithelium 
(Gallagher et al., 2003). In vivo studies on this line and 
the possible role of CS extract to regulate the 
expression of PPARγ and other related genes in HFD 
mice are in progress.  
 
CONCLUSION 
This inventory is however first report that has 
investigated role of CS extract in improvement of 
HFD induced IR. These results are attributable to 
multiple physiological processes such as CS extract 
induced decrement in food intake, lowering of plasma 
and tissue lipids and decrement in size of adipocytes. 
Also, CS extract induced lowering of insulin, 
eventually leading to improvement of IR, improved 
insulin sensitivity and efficient clearance of glucose 
load, further corroborate these observations. Since, 
protective role of CS extract against STZ induced type 
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I diabetes has already been established, this study is an 
addition to its already established pharmacotherapeutic 
uses. 
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